
N.S. to provide COVID-19 update at 3 p.m. AT as province reports 5 more deaths
CBC
Nova Scotia reported five deaths due to COVID-19 on Wednesday: a woman in her 60s in the northern zone, a woman in her 70s in the western zone, a woman in her 80s in the eastern zone and two women in their 90s in the central zone.
Premier Tim Houston and Chief Medical Officer of Health Dr. Robert Strang are expected to give an update on the province's COVID-19 situation Wednesday afternoon.
The news conference is scheduled for 3 p.m. AT and will be live streamed here.
On Wednesday, Nova Scotia reported 91 people were in a designated COVID-19 hospital unit, including 16 in intensive care.
The age range for those in hospital is 0 to 95 years old. The average age of those in hospital is 63, and those in hospital stay for an average of 8.4 days.
Since the Omicron wave began on Dec. 8, 56 Nova Scotians have died because of COVID-19.
Of those in hospital:
Currently, unvaccinated Nova Scotians are about 4.5 times more likely to be hospitalized or die due to COVID-19 than someone with two doses of the COVID-19 vaccine. That is based on average hospitalizations since the province started releasing daily hospitalization numbers by vaccine status on Jan. 4.
Unvaccinated people are also more than seven times as likely to die of COVID-19 than someone who had received a booster dose.
There are also two other groups of people in hospital related to COVID-19:
On Tuesday, volunteers assembling rapid COVID-19 tests celebrated the milestone of putting together one million kits.
Nova Scotia announced Wednesday it is recommending additional COVID-19 shots under certain circumstances for people between the ages of five and 17.
The province is recommending additional boosters for young people who are immunocompromised, those who live in crowded settings such as group homes, and people of colour or those who come from marginalized communities that have been disproportionately affected by COVID-19.
Immunocompromised children ages five to 11 are also now eligible for a third dose 56 days after their second dose.